A randomized clinical trial of bermekimab treatment for clinical improvement of systemic sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A randomized clinical trial of bermekimab treatment for clinical improvement of systemic sclerosis

Published:2023-09 Issue:9 Volume:26 Page:107670
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Solomonidi Nicky,Vlachoyiannopoulos Panayiotis G.,Pappa Maria,Liantinioti Georgia,Ktena Sofia,Theotikos Evangelos,Elezoglou Antonia,Netea Mihai G.,Giamarellos-Bourboulis Evangelos J.

Funder

Hellenic Institute for the Study of Sepsis

Janssen Pharmaceuticals

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference34 articles.

1. Systemic sclerosis: markers and targeted treatments;Cutolo;Acta Rheumatol. Port.,2016

2. Interstitial lung disease in systemic sclerosis: current and future treatment;Giacomelli;Rheumatol. Int.,2017

3. An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis;Denton;Ann Rheum,2009

4. Systemic sclerosis: hypothesis driven treatment strategies;Charles;Lancet,2006

5. Advances in pathogenesis and treatment of systemic sclerosis;Denton;Clin. Med.,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct fibroblast functions associated with fibrotic and immune-mediated inflammatory diseases and their implications for therapeutic development;F1000Research;2024-01-10

2. IL-1 Receptor Dynamics in Immune Cells: Orchestrating Immune Precision and Balance;Immune Network;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP